Home > Boards > US Listed > Biotechs > Stemline Therapeutics (STML)

Cut my loss

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
stockmarkot Member Profile
 
Followed By 19
Posts 1,232
Boards Moderated 0
Alias Born 11/28/12
160x600 placeholder
Stemline Therapeutics Highlights Recent Clinical and Regulatory Developments and Details Upcoming Milestones following its An... GlobeNewswire Inc. - 7/8/2019 5:50:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 5:18:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 5:17:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 5:17:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 5:17:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 5:16:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 5:16:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 5:16:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 5:15:29 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 6/28/2019 5:11:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/28/2019 4:32:51 PM
Stemline Therapeutics Announces Presentation of ELZONRIS (tagraxofusp) Preclinical Data in Systemic Sclerosis, an Autoimmune ... GlobeNewswire Inc. - 6/17/2019 7:30:00 AM
Stemline Therapeutics Announces Three ELZONRIS (tagraxofusp) Clinical Presentations at EHA Congress June 13-15 GlobeNewswire Inc. - 6/13/2019 7:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/11/2019 5:03:08 PM
Notice of Exempt Solicitation. Definitive Material. (px14a6g) Edgar (US Regulatory) - 6/11/2019 3:44:59 PM
Stemline Therapeutics Announces ASCO Presentation of ELZONRIS Phase 2 Clinical Data in CMML and MF; Provides Next Steps for C... GlobeNewswire Inc. - 6/3/2019 7:30:00 AM
Stemline Therapeutics Announces ELZONRIS Clinical Data Selected for Presentation at Upcoming EHA Annual Congress GlobeNewswire Inc. - 5/20/2019 7:00:00 AM
Stemline Therapeutics Announces ELZONRIS Clinical Data Selected for Presentation at the Upcoming ASCO Annual Meeting GlobeNewswire Inc. - 5/16/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 4:17:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/10/2019 7:31:17 AM
Stemline Therapeutics Reports First Quarter 2019 Financial Results GlobeNewswire Inc. - 5/10/2019 6:30:00 AM
Stemline Therapeutics to Host Conference Call on First Quarter 2019 Financial Results on May 10, 2019 GlobeNewswire Inc. - 5/8/2019 7:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/2/2019 6:03:32 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/30/2019 5:22:44 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2019 5:20:17 PM
stockmarkot   Tuesday, 05/05/15 03:24:22 PM
Re: None
Post # of 53 
Cut my loss

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist